Amgen Inc. (NASDAQ: AMGN) was reiterated as Outperform and the price target was raised to $189 from $175 (versus a $173.14 close) at Oppenheimer.
AngloGold Ashanti Ltd. (NYSE: AU) was downgraded to Sell from Neutral at Citigroup.
Aramark Corp. (NYSE: ARMK) was started with a Buy rating and assigned a $42 price target (versus a $35.97 close) at Deutsche Bank.
CoreCivic Inc. (NYSE: CXW) was started as Buy with a $38 price target (versus a $34.06 close) at Deutsche Bank.
DCP Midstream L.P. (NYSE: DPM) was raised to Buy from Neutral and the price target was raised to $45 from $37 (versus a $37.60 close) at UBS.
Ecolab Inc. (NYSE: ECL) was downgraded to Neutral from Buy at Longbow Research.
InterContinental Hotels Group PLC (NYSE: IHG) was downgraded to Equal Weight from Overweight at Barclays.
Juno Therapeutics Inc. (NASDAQ: JUNO) was started with an Outperform rating at Wells Fargo.
Kite Pharma Inc. (NASDAQ: KITE) was started with an Outperform rating at Wells Fargo.
Morgan Stanley (NYSE: MS) was started with a Neutral rating and assigned a $46 price target (versus a $46.56 close) at Compass Point.
Parker-Hannifin Corp. (NYSE: PH) was raised to Overweight from Neutral at JPMorgan.
Ralph Lauren Corp. (NYSE: RL) was downgraded to Underweight from Neutral at Atlantic Equities.
REV Group Inc. (NYSE: REVG) was started with a Buy rating and assigned a large upside target of $35 at Jefferies. Shares closed down 3.4% at $26.65 on Tuesday after the quiet period expiration brought mixed analyst calls, but Goldman Sachs being cautious may have done the most harm.
Sierra Oncology Inc. (SRRA) was assumed in new analyst coverage as Outperform with a $4 price target, up exponentially from the prior $1.41 closing price, at Wedbush Securities. The firm sees Sierra Oncology as having promising new assets targeting cancer.
STMicroelectronics N.V. (NYSE: STM) was raised to Overweight from Equal Weight at Barclays.
Texas Roadhouse Inc. (NASDAQ: TXRH) was reiterated as Underperform at Jefferies, but the price target was raised to $38 from $37 (versus a $47.79 close).
United Parcel Service Inc. (NYSE: UPS) was downgraded to Neutral from Buy with a $114 price objective (versus a $107.73 close) at Merrill Lynch.
VF Corp. (NYSE: VFC) was raised to Equal Weight from Underweight and the price target was raised to $50 from $48 at Morgan Stanley.